Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

VVOS Vivos Therapeutics Inc

6,29

1,17 (22,85%)

17 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Vivos Therapeutics Charts.

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Vivos Therapeutics Charts.

News Vivos Therapeutics Inc

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 26 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 23 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Montag 23 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 20 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 27 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 27 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
Dienstag 8 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Vivos Therapeutics Inc News-Artikel

Health Care Select Sector

BNP Paribas (QX)

Euro vs US Dollar

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen